|
1
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dzatic-Smiljkovic O, Vasiljevic M, Djukic
M, Vugdelic R and Vugdelic J: Frequency of ovarian endometriosis in
epithelial ovarian cancer patients. Clin Exp Obstet Gynecol.
38:394–398. 2011.PubMed/NCBI
|
|
3
|
Abugo OO and Rifkind JM: Oxidation of
hemoglobin and the enhancement produced by nitroblue tetrazolium. J
Biol Chem. 269:24845–24853. 1994.PubMed/NCBI
|
|
4
|
Shikama K and Matsuoka A: Human
haemoglobin: A new paradigm for oxygen binding involving two types
of alphabeta contacts. Eur J Biochem. 270:4041–4051. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polak G, Wertel I, Barczyński B,
Kwaśniewski W, Bednarek W and Kotarski J: Increased levels of
oxidative stress markers in the peritoneal fluid of women with
endometriosis. Eur J Obstet Gynecol Reprod Biol. 168:187–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reuter S, Gupta SC, Chaturvedi MM and
Aggarwal BB: Oxidative stress, inflammation, and cancer: How are
they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahalingaiah PK and Singh KP: Chronic
oxidative stress increases growth and tumorigenic potential of
MCF-7 breast cancer cells. PLoS One. 9:e873712014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akasaka J, Uekuri C, Shigetomi H, Koike M
and Kobayashi H: Hepatocyte nuclear factor (HNF)-1β and its
physiological importance in endometriosis. Biomed Rep. 1:13–17.
2013.PubMed/NCBI
|
|
9
|
Shigetomi H, Sudo T, Shimada K, Uekuri C,
Tsuji Y, Kanayama S, Naruse K, Yamada Y, Konishi N and Kobayashi H:
Inhibition of cell death and induction of G2 arrest accumulation in
human ovarian clear cells by HNF-1β transcription factor:
Chemosensitivity is regulated by checkpoint kinase CHK1. Int J
Gynecol Cancer. 24:838–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobayashi H, Kajihara H, Yamada Y, Tanase
Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Naruse
K, et al: Risk of carcinoma in women with ovarian endometrioma.
Front Biosci (Elite Ed). 3:529–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Liu X, Janes J, Stapley R, Patel
RP, Gladwin MT and Kim-Shapiro DB: Mechanism of faster NO
scavenging by older stored red blood cells. Redox Biol. 2:211–219.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cadet J, Delatour T, Douki T, Gasparutto
D, Pouget JP, Ravanat JL and Sauvaigo S: Hydroxyl radicals and DNA
base damage. Mutat Res. 424:9–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei H, Cai Q and Rahn RO: Inhibition of UV
light- and Fenton reaction-induced oxidative DNA damage by the
soybean isoflavone genistein. Carcinogenesis. 17:73–77. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kobayashi H, Kajiwara H, Kanayama S,
Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M,
Sado T and Oi H: Molecular pathogenesis of endometriosis-associated
clear cell carcinoma of the ovary (review). Oncol Rep. 22:233–240.
2009.PubMed/NCBI
|
|
15
|
Xue X and Shah YM: Intestinal iron
homeostasis and colon tumorigenesis. Nutrients. 5:2333–2351. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Toyokuni S: Mysterious link between iron
overload and CDKN2A/2B. J Clin Biochem Nutr. 48:46–49. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rolfs F, Huber M, Gruber F, Böhm F,
Pfister HJ, Bochkov VN, Tschachler E, Dummer R, Hohl D, Schäfer M,
et al: Dual role of the antioxidant enzyme peroxiredoxin 6 in skin
carcinogenesis. Cancer Res. 73:3460–3469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S
and Chen L: Clinical implications of high NQO1 expression in breast
cancers. J Exp Clin Cancer Res. 33:142014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanase Y, Yamada Y, Shigetomi H, Kajihara
H, Oonogi A, Yoshizawa Y, Furukawa N, Haruta S, Yoshida S, Sado T,
et al: Modulation of estrogenic action in clear cell carcinoma of
the ovary (Review). Exp Ther Med. 3:18–24. 2012.PubMed/NCBI
|
|
20
|
Kajihara H, Yamada Y, Shigetomi H,
Higashiura Y and Kobayashi H: The dichotomy in the histogenesis of
endometriosis-associated ovarian cancer: Clear cell-type versus
endometrioid-type adenocarcinoma. Int J Gynecol Pathol. 31:304–312.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamada Y, Shigetomi H, Onogi A, Haruta S,
Kawaguchi R, Yoshida S, Furukawa N, Nagai A, Tanase Y, Tsunemi T,
et al: Redox-active iron-induced oxidative stress in the
pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol
Cancer. 21:1200–1207. 2011.PubMed/NCBI
|
|
22
|
Itamochi H, Kigawa J, Akeshima R, Sato S,
Kamazawa S, Takahashi M, Kanamori Y, Suzuki M, Ohwada M and
Terakawa N: Mechanisms of cisplatin resistance in clear cell
carcinoma of the ovary. Oncology. 62:349–353. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pectasides D, Pectasides E, Psyrri A and
Economopoulos T: Treatment issues in clear cell carcinoma of the
ovary: A different entity? Oncologist. 11:1089–1094. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshida S, Furukawa N, Haruta S, Tanase Y,
Kanayama S, Noguchi T, Sakata M, Yamada Y, Oi H and Kobayashi H:
Theoretical model of treatment strategies for clear cell carcinoma
of the ovary: Focus on perspectives. Cancer Treat Rev. 35:608–615.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mogami T, Yokota N, Asai-Sato M, Yamada R,
Koizume S, Sakuma Y, Yoshihara M, Nakamura Y, Takano Y, Hirahara F,
et al: Annexin A4 is involved in proliferation, chemo-resistance
and migration and invasion in ovarian clear cell adenocarcinoma
cells. PLoS One. 8:e803592013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsuda H, Ito YM, Ohashi Y, Wong KK,
Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ and Mok SC:
Identification of overexpression and amplification of ABCF2 in
clear cell ovarian adenocarcinomas by cDNA microarray analyses.
Clin Cancer Res. 11:6880–6888. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kajihara H, Yamada Y, Kanayama S, Furukawa
N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H and Kobayashi H:
Clear cell carcinoma of the ovary: Potential pathogenic mechanisms
(Review). Oncol Rep. 23:1193–1203. 2010.PubMed/NCBI
|
|
28
|
Mandai M, Matsumura N, Baba T, Yamaguchi
K, Hamanishi J and Konishi I: Ovarian clear cell carcinoma as a
stress-responsive cancer: Influence of the microenvironment on the
carcinogenesis and cancer phenotype. Cancer Lett. 310:129–133.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamaguchi K, Huang Z, Matsumura N, Mandai
M, Okamoto T, Baba T, Konishi I, Berchuck A and Murphy SK:
Epigenetic determinants of ovarian clear cell carcinoma biology.
Int J Cancer. 135:585–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hecht JL, Kotsopoulos J, Hankinson SE and
Tworoger SS: Relationship between epidemiologic risk factors and
hormone receptor expression in ovarian cancer: Results from the
Nurses' Health Study. Cancer Epidemiol Biomarkers Prev.
18:1624–1630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iida Y, Aoki K, Asakura T, Ueda K,
Yanaihara N, Takakura S, Yamada K, Okamoto A, Tanaka T and Ohkawa
K: Hypoxia promotes glycogen synthesis and accumulation in human
ovarian clear cell carcinoma. Int J Oncol. 40:2122–2130.
2012.PubMed/NCBI
|
|
32
|
Cuff J, Salari K, Clarke N, Esheba GE,
Forster AD, Huang S, West RB, Higgins JP, Longacre TA and Pollack
JR: Integrative bioinformatics links HNF1B with clear cell
carcinoma and tumor-associated thrombosis. PLoS One. 8:e745622013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dai Y and Grant S: New insights into
checkpoint kinase 1 in the DNA damage response signaling network.
Clin Cancer Res. 16:376–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zharkov DO: Base excision DNA repair. Cell
Mol Life Sci. 65:1544–1565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smith J, Tho LM, Xu N and Gillespie DA:
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and
cancer. Adv Cancer Res. 108:73–112. 2010.PubMed/NCBI
|
|
36
|
Reinhardt HC and Yaffe MB: Kinases that
control the cell cycle in response to DNA damage: Chk1, Chk2, and
MK2. Curr Opin Cell Biol. 21:245–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sugiyama T, Kamura T, Kigawa J, Terakawa
N, Kikuchi Y, Kita T, Suzuki M, Sato I and Taguchi K: Clinical
characteristics of clear cell carcinoma of the ovary: A distinct
histologic type with poor prognosis and resistance to
platinum-based chemotherapy. Cancer. 88:2584–2589. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Reed E, Yu JJ, Davies A, Gannon J and
Armentrout SL: Clear cell tumors have higher mRNA levels of ERCC1
and XPB than other histological types of epithelial ovarian cancer.
Clin Cancer Res. 9:5299–5305. 2003.PubMed/NCBI
|
|
39
|
Mao TL and Shih IeM: The roles of ARID1A
in gynecologic cancer. J Gynecol Oncol. 24:376–381. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsuchiya A, Sakamoto M, Yasuda J, Chuma M,
Ohta T, Ohki M, Yasugi T, Taketani Y and Hirohashi S: Expression
profiling in ovarian clear cell carcinoma: Identification of
hepatocyte nuclear factor-1 beta as a molecular marker and a
possible molecular target for therapy of ovarian clear cell
carcinoma. Am J Pathol. 163:2503–2512. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma CX, Ellis MJ, Petroni GR, Guo Z, Cai
SR, Ryan CE, Lockhart AC, Naughton MJ, Pluard TJ, et al: A phase II
study of UCN-01 in combination with irinotecan in patients with
metastatic triple negative breast cancer. Breast Cancer Res Treat.
137:483–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kaufmann SH, Karp JE, Litzow MR, Mesa RA,
Hogan W, Steensma DP, Flatten KS, Loegering DA, Schneider PA,
Peterson KL, et al: Phase I and pharmacological study of cytarabine
and tanespimycin in relapsed and refractory acute leukemia.
Haematologica. 96:1619–1626. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takano M, Kikuchi Y, Yaegashi N, Kuzuya K,
Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, et al:
Clear cell carcinoma of the ovary: A retrospective multicentre
experience of 254 patients with complete surgical staging. Br J
Cancer. 94:1369–1374. 2006. View Article : Google Scholar : PubMed/NCBI
|
